Principles of pharmacokinetics

Wylie and Churchill-Davidsons: A Practice of Anesthesia, Seventh Edition

Volumn , Issue , 2003, Pages 29-43

  Shafer, Steven L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85058726542     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (68)

1. Box G. Robustness in the strategy of scientific model building. In: Launer RL, Wilkerson, GN (eds). Robustness in Statistics. New York: Academic Press, 1979: 201-36.
2. Henthorn TK, Avram MJ, Krejcie TC, et al. Minimal compartmental model of circulatory mixing of indocyanine green. Am J Physiol 1992; 262 (3 Pt 2): 903-10.
3. Krejcie TC, Henthorn TK, Shanks CA, Avram MJ. A recirculatory pharrnacokinetic model describing the circulatory mixing, tissue distribution and elimination of antipyrine in dogs. J Pharmacal Exp Ther 1994; 269: 609-16.
4. Ludbrook GL, Upton RN, Grant C, Martinez A. The effect of rate of administration on brain concentrations of propofol in sheep. Anesth Analg1998; 86: 1301-6.
5. Boer F, Bovill JG, Burm AG, Mooren RA. Uptake of sufentanil, alfentanil and morphine in the lungs of patients about to undergo coronary artery surgery. Br J Anaesth 1992; 68: 370-5.
6. Roerig DL, Kotrly KJ, Vucins EJ. et al. First pass uptake of fentanyl, meperidine, and morphine in the human lung. Anesthesiology 1987; 67: 466-72.
7. Homer TO, Stanski DR. The effect of increasingageon thiopental disposition and anesthetic requirement. Anesthesiology 1985; 62: 714-24.
8. Stanski DR, Maitre PO. Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. Anesthesiology 1990; 72: 412-22.
9. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in aduIt volunteers. Anesthesiology 1998; 88: 1170-82.
10. Minto CF, Schnider TW, Egan TO, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10-23.
11. Forbes GB, Reina Jc. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970; 19: 653-63.
12. Greenblatt DJ, Arendt RM, Abernethy DR, et al. In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution. Br I Anaesth 1983; 55: 985-9.
13. Greenblatt DJ, Friedman H, Burstein ES, et al. Trazodone kinetics: effect of age, gender, and obesity. Clin Pharmacol Ther 1987; 42: 193-200.
14. Greenblatt DJ, Abernethy DR, Locniskar A, et al. Age, sex, and nitrazepam kinetics: relation to antipyrine disposition. Clin Pharmacol Ther 1985; 38: 697-703.
15. Scavone JM, Friedman H, Greenblatt DJ, Shader RI. Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats. Arzneimittelforschung 1987; 37: 2-6.
16. Meyer UA. Drugs in special patient groups: clinical importance of genetics in drug effects. In: Melmon KL, Morelli HF, Hoffman BB, Nierenberg DW(eds). ClinicalPharmacology. NewYork: McGraw-Hili, 1991.
17. Wilkinson GR, Shand DG. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 1975; 18: 377-90.
18. Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301.
19. Wood AJ, Vestal RE, Wilkinson GR, et al. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacal Ther 1979; 26: 16-20.
20. Vestal RE, Wood AJ. Influence of age and smoking on drug kinetics in man: studies using model compounds. Clin Pharmacokinet 1980; 5: 309-19.
21. Greenblatt DJ, Allen MD, Locniskar A, et al. Lorazepam kinetics in the elderly. Clin Pharmacol Ther 1979; 26: 103-13.
22. Kien ND, Reitan JA, White DA, et al. Hemodynamic responses to altentanil in halothane-anesthetized dogs.Anesth Analg 1986; 65: 765-70.
23. Thulin L, Andreen M, Irestedt L Effect of controlled halothane anaesthesia on splanchnic blood flow and cardiac output in the dog. Acta Anaesthesiol Scand 1975; 19: 146-53.
24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
25. Danziger RS, Tobin JD, Becker LC, et al. The age-associated decline in glomerular filtration in healthy normotensive volunteers. Lack of relation to cardiovascular performance. J AmGeriatrSoc 1990; 38: 1127-32.
26. Upton RA, Nguyen TL, Miller RD, Castagnoli N. Renal and biliary elimination of vecuronium (ORG NC45) and pancuronium in rats. Anesth Analg 1982; 61: 313-16.
27. Waxman K, Shoemaker WC, Lippmann M. Cardiovasculareffects of anesthetic induction with ketamine. Anesth Analg1980; 59: 355-8.
28. Bennett GM, Stanley TH. Cardiovasculareffects of fentanyl during enflurane anesthesia in man. Anesth Analg 1979; 58: 179-82.
29. Westenskow DR, Jordan WS, Hodges MR, Stanley TH. Correlation of oxygen uptake and cardiovascular dynamics during N, O-fentanyl and N, O-thiopental anesthesia in the dog. Anesth Analg 1978; 57: 37-41.
30. Liu W, Bidwai AV, Stanley TH, Isern-Amaral J. Cardiovascular dynamics after large doses of fentanyl and fentanyl plus N, O in the dog. Anesth Analg 1976; 55: 168-72.
31. Mallow JE, White RD, Cucchiara RF, Tarhan S. Hemodynamic effects of isoflurane and halothane in patients with coronary artery disease. Anesth Analg 1976; 55: 135-8.
32. Lappas DG, Buckley MJ, Laver MB, et al. Left ventricular performance and pulmonary circulation following addition of nitrous oxide to morphine during coronary-artery surgery.Anesthesiology 1975; 43: 61-9.
33. Fairfield JE, Dritsas A, Beale RJ. Haemodvnarmc effects of propofol: induction with 2.5 mg kg. Br J Anaesth 1991; 67: 618-20.
34. Brismar B, Hedenstierna G, Lundh R, Tokics L Oxygen uptake, plasma catecholamines and cardiac output during neurolept-nitrous oxide and halothane anaesthesias. ActaAnaesthesiol Scand 1982; 26: 541-9.
35. Pavlin DJ, Coda B, Shen DD, et at. Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers. Anesthesiology 1996; 84: 23-37.
36. Cockshott ID, Briggs LP, Douglas EJ, White M. Pharmacokinetics of propofol in female patients. Studies using single bolus injections. Br J Anaesth 1987; 59: 1103-10.
37. Rodeheffer RJ, Gerstenblith G, Becker LC, et al. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 1984; 69: 203-13.
38. Katori R. Normal cardiac output in relation to ageand body size. Tohoku J Exp Med 1979; 128: 377-87.
39. Youngs EJ, Shafer SL Pharmacokinetic parameters relevant to recovery from opioids. Anesthesiology 1994; 81: 833-42.
40. Shafer S. Principles of pharmacokinetics and pharmacodynamics. In: Longnecker DE, Tinker JH, Morgan GE (eds). Principles and Practice of Anesthesiology, 2nd edn. St. Louis: Mosby, 1997: 1159-1210.
41. Macklon AF, Barton M, James O, Rawlins MD. The effect of age on the pharmacokinetics of diazepam. ClinSci 1980; 59: 479-83.
42. Davis D, Grossman SH, Kitchell BB, et at. The effects of age and smoking on the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacoj 1985; 19: 261-5.
43. Ariens EJ. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. fur J Clin Pharmacal 1984; 26: 663-8.
44. Rutten AJ, Mather LE, McLean CF. Cardiovascular effects and regional clearances of i.v. bupivacaine in sheep: enantiomeric analysis. Br J Anaesth 1991; 67: 247-56.
45. Mather LE. Disposition of mepivacaine and bupivacaine enantiomers in sheep. Br J Anaesth 1991; 67: 239-46.
46. Tucker GT, Mather LE, Lennard MS, Gregory A. Plasma concentrations of the stereoisomers of prilocaine after administration of the racemate: implications for toxicity? Br] Anaesth 1990; 65: 333-6.
47. White PF, Ham J. Way WL, Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1980; 52: 231-9.
48. White PF, Schuttler J, Shafer A, et al. Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth 1985; 57: 197-203.
49. Persson J. Hasselstrom J. Maurset A, et al. Pharmacokinetics and non-anagesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity. fur J C1in Pharmacol 2002; 57: 869-75.
50. Ebling WF, Wada DR, Stanski DR. From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat. J Pharmawkinet Biopharm 1994; 22: 259-92.
51. Bjorkman S, Wada DR, Stanski DR, Ebling WF. Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models. J Pharmacokinet Biopharm 1994; 22: 381-410.
52. Olson RW. The Art of Creative Thinking. New York: HarperCollins, 1986.
53. Youngs EJ, Shafer SL. Basic pharmacokinetic and pharmacodynamic principles. In: White PF (ed.). Textbook oj Intravenous Anesthesia. Baltimore, MD: Williams & Wilkins, 1997: 10-26.
54. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53-63.
55. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76: 334-41.
56. Hull CJ, Van Beem HB, McLeod K, et al. A pharmacodynamic model for pancuronium. Br J Anaesth 1978; 50: 1113-23.
57. Sheiner LB, Stanski DR, Vozeh S, et al. Simultaneous modeling of phar- macokinetics and pharmacodynamics: application to d-tubocurarine. C1in Pharmacal Ther 1979; 25: 358-71.
58. Billard V, Gambus PL, Chamoun N, et al. A comparison of spectral edge, delta power, and bispectral index as EEG measuresof alfentanil, propofol, and midazolam drug effect. C1in Pharmacal Ther 1997; 61: 45-58.
59. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-16.
60. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacal ExpTher 1987; 240: 159-66.
61. Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effect comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991; 74: 34-42.
62. Glavinovic MI, Law Min JC, Kapural L, et al. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis. J Pharmacal Exp Ther 1993; 265: 1181-6.
63. Rupp SM, Castagnoli KP, Fisher OM, Miller RD. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults. Anesthesiology 1987; 67: 45-9.
64. Stanski DR, Ham J, Miller RD, Sheiner LB. Pharmacokinetics and pharmacodynamics of D-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man. Anesthesiology 1979; 51: 235-41.
65. Glass PS, Shafer SL, Reves JG. Intravenous anesthesia delivery systems. In: Miller RD (ed.). Anesthesia, 5th edn. New York: Churchill Livingston, 1999.
66. Zomorodi K, Donner A, Somma J, et al. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting. Anesthesiology 1998; 89: 1418-29.
67. Egan TO, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993; 79: 881-92.
68. Bailey JM. Technique for quantifying the duration of intravenous anesthetic effect. Anesthesiology 1995; 83: 1095-103.